REPORT : Consortium Led by Former QPR Star Submits £30m+ Bid for Reading FC…

INKAKHA eyayibamba ishisa kuBafana Bafana eNdebeni yoMhlaba eSouth Korea/Japan ngo-2002, uQuinton Fortune . Isithombe: Duif du Toit / Gallo Images

A new development in the takeover of Reading FC has surfaced, with reports indicating that a US-Saudi consortium led by former QPR player Marc Bircham has submitted a bid exceeding £30 million.

The League One club has experienced several seasons of instability under the ownership of Chinese businessman Dai Yongge at the Select Car Leasing Stadium.

Points deductions in both the Championship and League One have plagued the team in recent years, leading to a tumultuous period. The first of these deductions resulted in Reading’s first stint in League One since 2002.

Manager Ruben Selles faced additional challenges last season when six more points were deducted from Reading FC’s tally. Despite this setback, the Royals managed to finish nine points clear of the relegation zone.

However, just days after the club announced that a North American group, which had entered a period of exclusivity in March, had not yet reached an agreement, new hope has emerged. A report by the Reading Chronicle indicates renewed optimism with the latest bid.

According to the publication, days after the North American group, identified as Chiron, continued their bid to take over the club, another consortium officially submitted a bid to Dai Yongge.

This new bid, lodged on Friday, is reported to be in the range of £30-£35 million, making it the largest financial offer currently on the table for the club’s takeover.

The consortium is reportedly led by former Queens Park Rangers and Canada midfielder Marc Bircham, who has shown a “long-term interest” in Reading FC and attended numerous games throughout the 2023/24 season.

Marc Bircham, who made over 200 appearances for Millwall, Queens Park Rangers, and Yeovil Town between 1996 and 2009, transitioned into management after his playing career.

 

Be the first to comment

Leave a Reply

Your email address will not be published.


*